Ashley Cimino‐Mathews

8.1k citations

122 papers · 3.8k indexed · h-index 37

Oncology top 1%
- Cancer Immunotherapy and Biomarkers 22
- Cancer Cells and Metastasis 17
- HER2/EGFR in Cancer Research 15
Cancer Research top 2%
- Breast Cancer Treatment Studies 26
- Cancer Genomics and Diagnostics 17
Dermatology top 1%
- Cancer and Skin Lesions 15
Immunology top 5%
Pathology and Forensic Medicine top 2%
- Breast Lesions and Carcinomas 24
Pulmonary and Respiratory Medicine
- Metastasis and carcinoma case studies 13

Co-authors: Pedram Argani Rajni Sharma Leisha A. Emens Janis M. Taube Peter B. Illei Alan K. Meeker Elizabeth D. Thompson Ben Ho Park
Cited by: Oncology Cancer Research Dermatology
Journals: Proceedings of the National Academy of Sciences (1 paper)Nature Communications (1 paper)Journal of Clinical Oncology (7 papers)
Partner nations: United States Spain Germany

In The Last Decade

Ashley Cimino‐Mathews

113 papers receiving 3.8k citations

Peers

Countries citing papers authored by Ashley Cimino‐Mathews

Since Specialization

Citations

This map shows the geographic impact of Ashley Cimino‐Mathews's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ashley Cimino‐Mathews with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ashley Cimino‐Mathews more than expected).

Fields of papers citing papers by Ashley Cimino‐Mathews

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ashley Cimino‐Mathews. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ashley Cimino‐Mathews. The network helps show where Ashley Cimino‐Mathews may publish in the future.

Co-authorship network

The 25 scholars most cited alongside Ashley Cimino‐Mathews, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Ashley Cimino‐Mathews Line = papers co-authored together Ashley Cimino‐Mathews links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	Assessment of Estrogen Receptor, Progesterone Receptor, and Human Epidermal Growth Factor Receptor 2 on Cell Blocks and Core Needle Biopsies in Metastatic Breast Cancer: A Real-World Experience Acta Cytologica ·Chen Lossos,S. González Sánchez,Hiro Nonogaki,Edward Gabrielson,Ashley Cimino‐Mathews,Zahra Maleki	2025	1
2	1943P Updated pan-tumor guidelines for neoadjuvant scoring of pathologic response: A joint SITC and INMC effort Annals of Oncology ·J.S. Deutsch,Elizabeth M. Burton,Ashley Cimino‐Mathews,Tricia R. Cottrell,Carlos E. de Andrea,P-O. Fiset,Jeffrey E. Gershenwald,G.V. Long,Jane L. Messina,Roberto Salgado,Christian M. Schürch,Raja R. Seethala,Lynette M. Sholl,Sabina Signoretti,M.T. Tetzlaff,B. van de Wiel,Xiaowei Xu,Richard A. Scolyer,Janis M. Taube	2024	0
3	Pan-tumor harmonization of pathologic response assessment for standardized data collection in neoadjuvant IO trials (PATHdata): Final analysis of a multi-institutional reproducibility study. Journal of Clinical Oncology ·Julie S. Deutsch,Tricia R. Cottrell,Krista Y. Chen,Carlos E. de Andrea,Ezra Baraban,Pierre Fiset,Jaroslaw Jedrych,Christine Orr,Roberto Salgado,Christian M. Schürch,Richard A. Scolyer,Raja R. Seethala,Lynette M. Sholl,Sabina Signoretti,Michael T. Tetzlaff,Annikka Weissferdt,Xiaowei Xu,James Ziai,Ashley Cimino‐Mathews,Janis M. Taube	2024	0
4	Mapping the breast tumor microenvironment: proximity analysis reveals spatial relationships between macrophage subtypes and metastasis-initiating cancer cells Oncogene ·Eloïse M. Grasset,Atul Deshpande,Jae W. Lee,Yeonju Cho,Sarah M. Shin,Erin M. Coyne,Alexei Hernandez,Xuan Yuan,Zhehao Zhang,Ashley Cimino‐Mathews,Andrew J. Ewald,Won Jin Ho	2024	2
5	Diagnostic Approach to Mesenchymal and Spindle Cell Tumors of the Breast Advances in Anatomic Pathology ·Marissa J. White,Ashley Cimino‐Mathews	2024	0
6	BLM overexpression as a predictive biomarker for CHK1 inhibitor response in PARP inhibitor–resistant BRCA -mutant ovarian cancer Science Translational Medicine ·Nitasha Gupta,Tzu‐Ting Huang,Jayakumar R. Nair,Daniel An,Grant Zurcher,Erika J. Lampert,Ann McCoy,Ashley Cimino‐Mathews,Elizabeth M. Swisher,Marc R. Radke,Christina M. Lockwood,Jonathan Reichel,Chih-Yuan Chiang,Kelli M. Wilson,Ken Cheng,Darryl Nousome,Jung‐Min Lee	2023	17
7	Triple-negative breast cancer metastasis involves complex epithelial-mesenchymal transition dynamics and requires vimentin Science Translational Medicine ·Eloïse M. Grasset,Matthew Dunworth,Gaurav Sharma,Melanie Loth,Joseph A. Tandurella,Ashley Cimino‐Mathews,Melissa Gentz,Sydney A. Bracht,Meagan Haynes,Elana J. Fertig,Andrew J. Ewald	2022	111
8	Prognostic Utility of Breast Cancer Index to Stratify Distant Recurrence Risk in Invasive Lobular Carcinoma Clinical Cancer Research ·Raquel Nunes,Tal Sella,Kai Treuner,Jennifer M. Atkinson,Jenna Wong,Yi Zhang,Pedro Exman,David J. Dabbs,Andrea L. Richardson,Catherine A. Schnabel,Dennis C. Sgroi,Steffi Oesterreich,Ashley Cimino‐Mathews,Otto Metzger	2021	13
9	Clinical importance of high-mannose, fucosylated, and complex N-glycans in breast cancer metastasis JCI Insight ·Klára Ščupáková,Oluwatobi Adelaja,Benjamin Balluff,Vinay Ayyappan,Caitlin M. Tressler,Nicole M. Jenkinson,Britt S. R. Claes,Andrew P. Bowman,Ashley Cimino‐Mathews,Marissa J. White,Pedram Argani,Ron M. A. Heeren,Kristine Glunde	2021	62
10	Combination of PARP Inhibitor Olaparib, and PD-L1 Inhibitor Durvalumab, in Recurrent Ovarian Cancer: a Proof-of-Concept Phase II Study Clinical Cancer Research ·Erika J. Lampert,Alexandra S. Zimmer,Michelle R. Padget,Ashley Cimino‐Mathews,Jayakumar R. Nair,Yingmiao Liu,Elizabeth M. Swisher,James W. Hodge,Andrew B. Nixon,E. Hitt Nichols,Mohammadhadi Bagheri,Elliott Levy,Marc R. Radke,Stanley Lipkowitz,Christina M. Annunziata,Janis M. Taube,Seth M. Steinberg,Jung‐Min Lee	2020	150
11	Human epidermal growth factor 2 (HER2) in early stage uterine serous carcinoma: A multi-institutional cohort study Gynecologic Oncology ·Britt Erickson,Omar Najjar,Shari Damast,Adriana Blakaj,Joan Tymon‐Rosario,Maryam Shahi,Alessandro D. Santin,Molly Klein,Michelle Dolan,Ashley Cimino‐Mathews,Natália Buza,J. Stuart Ferriss,Rebecca L. Stone,Mahmoud A. Khalifa,Amanda N. Fader	2020	63
12	Tumour-infiltrating lymphocytes (TILs) and BRCA-like status in stage III breast cancer patients randomised to adjuvant intensified platinum-based chemotherapy versus conventional chemotherapy European Journal of Cancer ·Leonora W. de Boo,Ashley Cimino‐Mathews,Yoni Lubeck,Antonios Daletzakis,Mark Opdam,Joyce Sanders,Erik Hooijberg,Annelot van Rossum,Zuzana Loncová,Dietmar Rieder,Zlatko Trajanoski,Marieke A. Vollebergh,Marcelo Sobral‐Leite,Koen Van de Vijver,Annegien Broeks,R Wiel,Harm van Tinteren,Sabine C. Linn,Hugo M. Horlings,Marleen Kok	2020	18
13	Pan-Tumor Pathologic Scoring of Response to PD-(L)1 Blockade Clinical Cancer Research ·Julie E. Stein,Evan J. Lipson,Tricia R. Cottrell,Patrick M. Forde,Robert A. Anders,Ashley Cimino‐Mathews,Elizabeth D. Thompson,Mohamad E. Allaf,Mark Yarchoan,Josephine Feliciano,Hao Wang,Elizabeth M. Jaffee,Drew M. Pardoll,Suzanne L. Topalian,Janis M. Taube	2019	92
14	USCAP 2018 Abstracts: Genitourinary Pathology (894–1126) Modern Pathology ·Jason L. Hornick,Rhonda K. Yantiss,(unknown),Laura W. Lamps,Cme Subcommittee,Steven D. Billings,Shree Sharma,Informatics Subcommittee,Raja R. Seethala,Ilan Weinreb,David Kaminsky,Andea Zubair Baloch,Olca Baştürk,Gregory R. Bean,Daniel J. Brat,Amy Chadburn,Ashley Cimino‐Mathews	2018	3
15	Whole-Exome Sequencing of Metaplastic Breast Carcinoma Indicates Monoclonality with Associated Ductal Carcinoma Component Clinical Cancer Research ·Bracha Erlanger Avigdor,Katie Beierl,Christopher D. Gocke,Daniel J. Zabransky,Karen Cravero,Kelly Kyker‐Snowman,Berry Button,David Chu,Sarah Croessmann,Rory L. Cochran,Roisín M. Connolly,Ben Ho Park,Sarah J. Wheelan,Ashley Cimino‐Mathews	2017	29
16	Benign and low-grade fibroepithelial neoplasms of the breast have low recurrence rate after positive surgical margins Modern Pathology ·Morgan L. Cowan,Pedram Argani,Ashley Cimino‐Mathews	2016	47
17	NKX3.1 is expressed in ER-positive and AR-positive primary breast carcinomas Journal of Clinical Pathology ·Rebecca J Asch-Kendrick,Mark A. Samols,Mohammed Lilo,Andrea P. Subhawong,Rajni Sharma,Peter B. Illei,Pedram Argani,Ashley Cimino‐Mathews	2014	22
18	HOXB13 Mediates Tamoxifen Resistance and Invasiveness in Human Breast Cancer by Suppressing ERα and Inducing IL-6 Expression Cancer Research ·Nilay Shah,Kideok Jin,Leigh-Ann Cruz,Sunju Park,Helen Sadik,Soonweng Cho,Chirayu Goswami,Harikrishna Nakshatri,Rajnish A. Gupta,Howard Y. Chang,Zhe Zhang,Ashley Cimino‐Mathews,Leslie Cope,Christopher B. Umbricht,Saraswati Sukumar	2013	76
19	Metastatic triple-negative breast cancers at first relapse have fewer tumor-infiltrating lymphocytes than their matched primary breast tumors: a pilot study Human Pathology ·Ashley Cimino‐Mathews,Xiaobu Ye,Alan K. Meeker,Pedram Argani,Leisha A. Emens	2013	101
20	Neural crest transcription factor Sox10 is preferentially expressed in triple-negative and metaplastic breast carcinomas Human Pathology ·Ashley Cimino‐Mathews,Andrea P. Subhawong,Hillary Elwood,Hind Nassar Warzecha,Rajni Sharma,Ben Ho Park,Janis M. Taube,Peter B. Illei,Pedram Argani	2012	122

About Ashley Cimino‐Mathews

Ashley Cimino‐Mathews is a scholar working on Cancer Research, Oncology and Pathology and Forensic Medicine, having authored 122 papers that have together received 3.8k indexed citations. Recurring topics across this work include Breast Cancer Treatment Studies (26 papers), Breast Lesions and Carcinomas (24 papers), Cancer Immunotherapy and Biomarkers (22 papers), Cancer Cells and Metastasis (17 papers), Cancer Genomics and Diagnostics (17 papers), HER2/EGFR in Cancer Research (15 papers), Cancer and Skin Lesions (15 papers) and Metastasis and carcinoma case studies (13 papers). The work is most often cited by research in Oncology (2.2k citations), Cancer Research (922 citations) and Dermatology (405 citations). Ashley Cimino‐Mathews has collaborated with scholars based in United States, Spain and Germany. Frequent co-authors include Pedram Argani, Rajni Sharma, Leisha A. Emens, Janis M. Taube, Peter B. Illei, Alan K. Meeker, Elizabeth D. Thompson, Ben Ho Park, Andrea P. Subhawong and Russell Vang. Their work appears in journals such as Proceedings of the National Academy of Sciences, Nature Communications and Journal of Clinical Oncology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact